Abstract
Ample evidence supports a role for tumour necrosis factor α (TNFα) in the development of type 2 diabetes and cardiovascular disease. TNFα expression was found to be influenced by a −308G/A polymorphism in the promoter of the gene encoding TNFα (TNF). We investigated the contribution of this polymorphism to diabetes and cardiovascular mortality in a population-based cohort of 664 subjects aged 85 years and over (Leiden 85-plus Study). The −308G/A TNF promoter polymorphism was associated with the prevalence of diabetes in old age (P = 0.006). The risk of diabetes among subjects homozygous for the A-allele was estimated to be 4.6-fold (95% CI, 1.6–13.3) higher than among subjects homozygous for the common G-allele. The promoter polymorphism did not, however, predict mortality from all causes, cardiovascular diseases, cancer or infectious diseases during a 10-year follow-up period. In addition to the promoter polymorphism, TNFa and TNFc microsatellite genotypes were determined but these polymorphisms were not associated with morbidity or mortality. In conclusion, the −308G/A polymorphism in the TNF promoter is strongly associated with the risk of diabetes but not cardiovascular mortality in old age.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS . Detection and localization of tumor necrosis factor in human atheroma Am J Cardiol 1990 65: 297–302
Lee RT, Libby P . The unstable atheroma Arterioscler Thromb Vasc Biol 1997 17: 1859–1867
Hotamisligil GS, Shargill NS, Spiegelman BM . Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 1993 259: 87–91
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS . Protection from obesity-induced induced insulin resistance in mice lacking TNFα function Nature 1997 389: 610–614
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM . Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance J Clin Invest 1995 95: 2409–2415
Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H . Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus Arterioscler Thromb Vasc Biol 1998 18: 1199–1202
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM . Tumor necrosis factor α inhibits signaling from the insulin receptor Proc Natl Acad Sci USA 1994 91: 4854–4858
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW . Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation Proc Natl Acad Sci USA 1997 94: 3195–3199
Kroeger KM, Carville KS, Abraham LJ . The −308 tumor necrosis factor-α promoter polymorphism effects transcription Mol Immunol 1997 34: 391–399
Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans Clin Exp Immunol 1998 113: 401–406
Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus Eur J Immunol 1993 23: 224–231
Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL . Relevance of the tumor necrosis factor α (TNF α) −308 promoter polymorphism in TNF α gene regulation J Inflamm 1995 46: 32–41
Herrmann SM, Ricard S, Nicaud V et al. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity Eur J Clin Invest 1998 28: 59–66
Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J . Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin Diabetologia 1991 34: 350–355
Tuomilehto-Wolf E, Tuomilehto J, Hitman GA et al. Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region BMJ 1993 307: 155–159
Hamann A, Mantzoros C, Vidal-Puig A, Flier JS . Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM) Biochem Biophys Res Commun 1995 211: 833–839
Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARγ Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes Nat Genet 2000 26: 76–80
Fernández-Real JM, Gutierrez C, Ricart W et al. The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels Diabetes 1997 46: 1468–1472
Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O . The −238 and −308 G→A polymorphisms of the tumor necrosis factor α gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians J Clin Endocrinol Metab 2000 85: 1731–1734
Francis SE, Camp NJ, Dewberry RM et al. Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease Circulation 1999 99: 861–866
Wang XL, Oosterhof J . Tumour necrosis factor α G-308→A polymorphism and risk for coronary artery disease Clin Sci (Colch) 2000 98: 435–437
Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RGJ . Total cholesterol and risk of mortality in the oldest old Lancet 1997 350: 1119–1123
Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW . An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles J Exp Med 1993 177: 557–560
O’Dell SD, Humphries SE, Day IN . Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example Br Heart J 1995 73: 368–371
World Health Organization. International Classification of Diseases: Manual of the International Statistical Classification ofDiseases, Injuries, and Causes of Death World Health Organization: Geneva 1977
Schneider S, Kueffer JM, Roessli D, Excoffier L . Arlequin ver. 1.1: A Software for Population Genetic Data Analysis Genetics and Biometry Laboratory, University of Geneva: Geneva 1997
Acknowledgements
We wish to thank the Central Bureau of Statistics for generously making available the mortality statistics and database linking.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grant no. 94.047 from The Netherlands Heart Foundation.
Rights and permissions
About this article
Cite this article
Heijmans, B., Westendorp, R., Droog, S. et al. Association of the tumour necrosis factor α −308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun 3, 225–228 (2002). https://doi.org/10.1038/sj.gene.6363859
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363859
Keywords
This article is cited by
-
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
Inflammopharmacology (2023)
-
TNF A −308G>A polymorphism in Moroccan patients with type 2 diabetes mellitus: a case–control study and meta-analysis
Molecular Biology Reports (2014)
-
The TNF-alpha -308G/A polymorphism is associated with type 2 diabetes mellitus: an updated meta-analysis
Molecular Biology Reports (2014)
-
Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes
BMC Medical Genetics (2010)
-
Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians
Journal of Molecular Medicine (2010)